• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. 20 G X 1.00 IN. BD NEXIVA¿ CLOSED IV CATHETER SYSTEM WITH DUAL PORT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. 20 G X 1.00 IN. BD NEXIVA¿ CLOSED IV CATHETER SYSTEM WITH DUAL PORT Back to Search Results
Catalog Number 383536
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/18/2017
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that the safety failed on a 20 g x 1.00 in.Bd nexiva¿ closed iv catheter system with dual port during use.No injury or medical intervention.
 
Manufacturer Narrative
Correction: date received by manufacturer: 09/18/2017.
 
Event Description
It was reported that the safety failed on a 20 g x 1.00 in.Bd nexiva¿ closed iv catheter system with dual port during use.No injury or medical intervention.
 
Manufacturer Narrative
Investigation summary: safety shield activation failure.Device/batch history record review: findings: the lot number 7131593 was manufactured on nfa line 1.Although there was 1 qn¿s ((b)(4)) initiated during its production, the failure was not relatable.In process samples including (but not limited to) correct assembly/proper retraction, machine caused damage and the occlusion test calibration all passed per specification.(b)(4) was in place during manufacturing under which 240 samples were pulled throughout the batch and tested for flashback.All samples tested passed.Representative sample analysis: received three nexiva 20ga units within sealed packages from lot number 7131593.All components were present and intact.Observed there was no mechanical/physical damage to any of the components.There were no wrinkles or kinks in the tubing.The cannula and catheter tips were acceptable per specifications and the lie distance was within the acceptable range of 0.001 - 0.031 inches.Flashback test: using a lab supplied artificial vein with a red dye/water mix performed a simulation of the venipuncture.Observed that upon penetration of the needle into the artificial vein; the initial flashback visualization could be seen rapidly in the chamber of the catheter/adapter.There were no obstructions inhibiting the flashback therefore, the unit demonstrated an acceptable flashback; fluid took less than one second to show a visible flow through the notch.Functional: the units were manually disengaged and retracted successfully and no drag/grinding was felt, the v-clip performed as intended and the needle stayed secured.Investigation conclusion: the representative units tested met all specification requirements.The failures experienced by the customer were not confirmed.The flashback and functional (disengagement) were successful.Reproduction of the failures that the customer experienced was not achieved with the evaluation and testing performed on the units received in the laboratory environment.Root cause description: the returned representative units did not display any adverse characteristics that would contribute to the defect the customer experienced.The defects described in the incident report could not be confirmed or replicated.The actual unit described in the incident report was not returned for evaluation.No root cause could be determined through the investigation: though the defect of "flashback (poor/no)" could not be confirmed, capa (b)(4) has been initiated to address the occurrence of the defect as stated in the verbatim of the pir.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
20 G X 1.00 IN. BD NEXIVA¿ CLOSED IV CATHETER SYSTEM WITH DUAL PORT
Type of Device
CLOSED IV CATHETER SYSTEM
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
brett wilko
9450 south state street
sandy, UT 84070
8015652845
MDR Report Key6879327
MDR Text Key87863997
Report Number1710034-2017-00235
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K102520
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 09/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/20/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date04/30/2020
Device Catalogue Number383536
Device Lot Number7131593
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/13/2017
Is the Reporter a Health Professional? No
Date Manufacturer Received09/18/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/11/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-